DE814315C - Process for the production of serums, vaccines and the like like - Google Patents

Process for the production of serums, vaccines and the like like

Info

Publication number
DE814315C
DE814315C DEB3021A DEB0003021A DE814315C DE 814315 C DE814315 C DE 814315C DE B3021 A DEB3021 A DE B3021A DE B0003021 A DEB0003021 A DE B0003021A DE 814315 C DE814315 C DE 814315C
Authority
DE
Germany
Prior art keywords
bacteria
production
vaccines
serums
antigens
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DEB3021A
Other languages
German (de)
Other versions
DE1617355U (en
Inventor
K H Ladislaus Dr Med Szabo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda GmbH
Original Assignee
Byk Gulden Lomberg Chemische Fabrik GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Byk Gulden Lomberg Chemische Fabrik GmbH filed Critical Byk Gulden Lomberg Chemische Fabrik GmbH
Priority to DEB3021A priority Critical patent/DE814315C/en
Application granted granted Critical
Publication of DE814315C publication Critical patent/DE814315C/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Description

Verfahren zur Herstellung von Seren, Impfstoffen u. dgl.Process for the production of serums, vaccines and the like.

Man hat bisher zur Bakterienzüchtung zwecks Impfstoffherstellung hauptsächlich Rinderbouillon, Rinderbouillonagar, Hammelblutagar oder Pferdeblutagar als Nährböden verwendet. So far one has to cultivate bacteria for the purpose of vaccine production mainly beef broth, beef broth agar, mutton blood agar or horse blood agar used as nutrient media.

Es wurde nun gefunden, daß die Ernährung der Bakterien auf ihren serologischen Antigencharakter einen entscheidenden Einfluß ausübt. In einem infizierten lebenden Organismus sind nämlich die Bakterien ganz anders ernährt als z. B. auf Agarplatten. Wenn man nun zur Serumherstellung lebende oder abgetötete Bakterien oder weiter gereinigte Antigene nimmt, die aus Agarkulturen stammen, so sind die gewonnenen Sera vielmehr auf Agarbakterien spezifisch als auf die Bakterien, die in einem lebenden Organismus schmarotzen. It has now been found that the nutrition of the bacteria on their serological antigenic character exerts a decisive influence. In an infected living organism, the bacteria are nourished quite differently than z. B. on Agar plates. If you now use live or killed bacteria for the production of serum or takes further purified antigens derived from agar cultures, so are those Sera obtained are more specific to agar bacteria than to the bacteria that parasitic in a living organism.

Rlan muß also hei der Serumherstellung für menschliche Zwecke die Antigene, mit denen man z. B. Pferde immunisiert, ausschließlich aus auf menschlichem Material gezüchteten Bakterien gewinnen, damit die Ernährung der Bakterien den Verhältnissen in dem infizierten menschlichen Organismus entspricht. Wenn man für tierische Zwecke Sera herstellt, muß man immer wieder zur Züchtung der Bakterien zwecks Antigengewinnung das Material derjenigen Tierart als Nährboden nehmen, welche man durch dieses Serum heilen will.So Rlan must be used in the production of serum for human purposes Antigens with which one can e.g. B. Horses immunized exclusively from on human Material cultured bacteria win so that the nutrition of the bacteria the ratios in the infected human organism. If you are for animal purposes If you produce sera, you have to keep growing the bacteria for the purpose of obtaining antigens take the material of the animal species as a nutrient medium, which one can get through this serum want to heal.

Die gleichen Gesetze sind auch für die Herstellung von Impfstoffen, Toxinen, Antigenen und Antivirus gültig. The same laws are also for the manufacture of vaccines, Toxins, antigens and antivirus valid.

Es entstehen offenbar durch die synthetisierende Fähigkeit der Bakterien immer verschiedene Anti- genverbindungen, die in ihrer Zusammensetzung von den zur Verfügung stehenden Nährsubstanzen abhängig sind und die mittels Praecipitation nachweisbar sind. Man muß also stets diejenige Art von Antigen als Impfstoff anwenden, die für die betreffende Tierart oder für den Menschen spezifisch ist. They evidently arise through the synthesizing ability of the bacteria always different anti gene compounds in their composition are dependent on the nutrients available and which are produced by means of precipitation are detectable. So you always have to use the type of antigen as a vaccine which is specific for the animal species concerned or for humans.

Beispiel Wenn man eine Reihe von Mäusen mit sicher tödlich wirkenden Mengen von lebenden Colibazillen i. p. infiziert und nun versucht, diese Mäuse bei gleichzeitiger intravenöser Verabreichung eines Coliserums vor dem Tode zu retten, so stellt sich heraus, daß man solche Mäuse mit einem Serum, das durch Züchtung und darauffolgende Abtötung der Colibazillen auf Nährböden aus Mäuseorganen, z.. B. Mäuseleber-, -muskel, -gehirn, -haut usw., gewonnen wurde, wobei diese Vakzine dann Kaninchen gespritzt und daraus in üblicher Immunisierungsweise das Serum erhalten wurde, in viel höheren Verdünnungen vom Tode retten kann als mit Sera, die von Kaninchen dadurch gewonnen sind, daß man diese mit auf Bouillonagar gezüchteten und abgetöteten Colibazillen immunisiert hat. Example if you have a number of mice with certain fatal effects Lots of live coli bacilli i. p. infected and now tried these mice at simultaneous intravenous administration of a coliserum to save from death, it turns out that such mice can be obtained with a serum obtained by breeding and subsequent killing of the Colibacilli on culture media from mouse organs, e.g. B. mouse liver, muscle, brain, skin, etc., was obtained, with this vaccine then injected rabbits and obtained the serum from it in the usual immunization manner can save death in much higher dilutions than with sera obtained from rabbits are obtained by having these cultured on bouillon agar and killed Immunized coli bacilli.

Wenn man eine Reihe von Mäusen mit einer Colivakzine i. v. immunisiert, wobei die Bazillen durch das obige Züchtungsverfahren aus Mäusematerial gewonnen sind, so ist diese Vakzine ebenso in viel höheren Verdünnungen imstande, die Mäuse gegenüber einer tödlichen Coliinfektion zu schützen, als eine Vakzine, gewonnen aus einer Coli-Bouillon-Agar-Kultur-Aufschwemmung. Solche Beispiele lassen sich mit beliebigen Bakterienarten und Tierspecies durchführen.If you have a number of mice with a coliva vaccine i. v. immunized, the bacilli obtained from mouse material by the above cultivation method this vaccine is also capable in much higher dilutions, the mice to protect against a fatal coli infection, as a vaccine from a coli broth agar culture suspension. Such examples can be with any type of bacteria and animal species.

Claims (1)

PATENTANSPRUCH: Verfahren zur Herstellung von Seren und Impfstoffen oder sonstigen für bakteriologische Zwecke dienenden Toxinen, Antigenen, Antivirus u. dgl., dadurch gekennzeichnet, daß die Antigene oder Antivirus aus solchen Bakterien oder Bakterienkulturfiltraten gewonnen werden, die auf Nährböden, z. B. Vollextrakt der gesamten Organe, oder durch Hydrolyse oder andere Verfahren gewonnene Abbausubstanzen, der gleichen Art von Lebewesen gezüchtet sind, bei welchen das Serum oder der Impfstoff angewendet wird. PATENT CLAIM: Process for the production of serums and vaccines or other toxins, antigens, antiviruses used for bacteriological purposes and the like., characterized in that the antigens or antivirus from such bacteria or bacterial culture filtrates are obtained which are grown on nutrient media, e.g. B. Whole Extract of the entire organs, or degradation substances obtained by hydrolysis or other processes, the same species of living being bred in which the serum or vaccine is applied.
DEB3021A 1950-04-13 1950-04-13 Process for the production of serums, vaccines and the like like Expired DE814315C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DEB3021A DE814315C (en) 1950-04-13 1950-04-13 Process for the production of serums, vaccines and the like like

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DEB3021A DE814315C (en) 1950-04-13 1950-04-13 Process for the production of serums, vaccines and the like like

Publications (1)

Publication Number Publication Date
DE814315C true DE814315C (en) 1951-09-20

Family

ID=6953013

Family Applications (1)

Application Number Title Priority Date Filing Date
DEB3021A Expired DE814315C (en) 1950-04-13 1950-04-13 Process for the production of serums, vaccines and the like like

Country Status (1)

Country Link
DE (1) DE814315C (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1032890B (en) * 1954-10-15 1958-06-26 Fernand Gauchard Process for the production of therapeutically effective products

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1032890B (en) * 1954-10-15 1958-06-26 Fernand Gauchard Process for the production of therapeutically effective products

Similar Documents

Publication Publication Date Title
Kubes et al. The causative agent of infectious equine encephalomyelitis in Venezuela
CH504532A (en) Attenuated strain of feline enteritis virus - from cell cultures
DE814315C (en) Process for the production of serums, vaccines and the like like
Blum et al. Trans-2-hexenal in the scent gland of the hemipteran Acanthocephala femorata
DE841333C (en) Process for the production of bacterial preparations from Treponema Pallidum
DE191752C (en)
Roe et al. Thalidomide and neoplasia
US1990982A (en) Biological medicament
Hwang et al. Synthesis, cytopathogenicity, and modification of avian encephalomyelitis virus (AEV) in chick kidney cell culture.
DE2162013C3 (en) Live rabies vaccine, process for its preparation and use in the control of rabies
Tyzzer The isolation in culture of grahamellae from various species of small rodents
Chadwick Effects of immunization on the LD50 of two pathogens of Galleria mellonella
DE250401C (en)
US2112507A (en) Process of producing vaccine lymph
DE1467849A1 (en) Process for the production of vaccines
Sherman et al. The germicidal action of milk.
Hooser et al. Elimination of pleuropneumonia-like organisms from embryonic human lung tissue culture with tetracycline
Smith et al. Isolation of Histoplasma capsulatum from soil by direct culture methods
AT117206B (en) Process for the manufacture of vaccines.
DE2121237C3 (en) Using a cell line to grow viruses
DE1904001C (en) Process for the production of a vac cine against meningitis cerebrospinalis
AT96830B (en) Process for producing a culture medium for influenza bacilli and for producing vaccines therefrom.
DE525484C (en) Process for the production of effective medicines and vaccines
Cavalcanti Scientific Institutions in Latin America: The Butantan Institute
Reid et al. Synthesis of ascorbic acid in excised roots of the white moonflower